Therefore, the present study aims to describe the current status and new findings of this key SCA7 population, including clinical, genetic, demographic, and epidemiological aspects, highlighting their contribution to the diagnosis, clinical management, and potential treatment of SCA7. The gene discussed is ATXN7; the disease is spinocerebellar ataxia 7.